Exhibit 99.3

ASML - Summary US GAAP Consolidated Statements of Operations ^1,2 

	Three months ended,
	Apr 3,		Apr 2,
	2016		2017
(in millions EUR, except per share data)
Net system sales 3	859.8		1,215.8
Net service and field option sales 3	473.4		727.8
Total net sales	1,333.2		1,943.6
Total cost of sales	(765.1	)	(1,019.0	)
Gross profit	568.1		924.6
Other income	23.4		23.9
Research and development costs	(274.7	)	(315.1	)
Selling, general and administrative costs	(88.8	)	(98.6	)
Income from operations	228.0		534.8
Interest and other, net	(3.6	)	(14.1	)
Income before income taxes	224.4		520.7
Benefit from (provision for) income taxes	(26.4	)	(68.6	)
Net income	198.0		452.1
Basic net income per ordinary share	0.46		1.05
Diluted net income per ordinary share 4	0.46		1.05
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic	427.0		430.1
Diluted 4	429.1		432.3

ASML - Ratios and Other Data ^1,2 

	Three months ended,
	Apr 3,		Apr 2,
	2016		2017
(in millions EUR, except otherwise indicated)
Gross profit as a percentage of net sales	42.6	%	47.6	%
Income from operations as a percentage of net sales	17.1	%	27.5	%
Net income as a percentage of net sales	14.9	%	23.3	%
Income taxes as a percentage of income before income taxes	11.7	%	13.2	%
Shareholders’ equity as a percentage of total assets	63.2	%	59.1	%
Sales of lithography systems (in units) 5	33		44
Value of systems backlog (EUR millions) 6	3,018		4,509
Lithography systems backlog (in units) 5	76		94
Value of booked systems (EUR millions) 6	835		1,894
Net lithography bookings (in units) 5	30		55
Number of payroll employees in FTEs	12,407		14,483
Number of temporary employees in FTEs	2,492		2,657

ASML - Summary US GAAP Consolidated Balance Sheets ^1,2 

	Dec 31,	Apr 2,
	2016	2017
(in millions EUR)
ASSETS
Cash and cash equivalents	2,906.9	2,910.6
Short-term investments	1,150.0	925.0
Accounts receivable, net	700.2	864.8
Finance receivables, net	447.4	346.9
Current tax assets	11.6	137.0
Inventories, net	2,780.9	2,995.7
Other assets	560.4	589.6
Total current assets	8,557.4	8,769.6
Finance receivables, net	117.2	213.6
Deferred tax assets	34.9	34.5
Other assets	612.3	621.1
Goodwill	4,873.9	4,784.1
Other intangible assets, net	1,323.0	1,279.5
Property, plant and equipment, net	1,687.2	1,622.4
Total non-current assets	8,648.5	8,555.2
Total assets	17,205.9	17,324.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities	3,280.6	2,875.4
Long-term debt	3,071.8	3,040.3
Deferred and other tax liabilities	396.9	410.1
Provisions	20.5	20.5
Accrued and other liabilities	615.7	735.5
Total non-current liabilities	4,104.9	4,206.4
Total liabilities	7,385.5	7,081.8
Total shareholders’ equity	9,820.4	10,243.0
Total liabilities and shareholders’ equity	17,205.9	17,324.8

ASML - Summary US GAAP Consolidated Statements of Cash Flows ^1,2 

	Three months ended,
	Apr 3,		Apr 2,
	2016		2017
(in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	198.0		452.1
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	82.0		110.1
Impairment	0.5		0.2
Loss on disposal of property, plant and equipment	1.2		0.3
Share-based payments	13.2		13.5
Allowance for doubtful receivables	0.9		1.2
Allowance for obsolete inventory	36.6		29.3
Deferred income taxes	(4.5	)	16.3
Changes in assets and liabilities	(333.7	)	(791.4	)
Net cash provided by (used in) operating activities	(5.8	)	(168.4	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(55.2	)	(38.6	)
Purchase of intangible assets	(3.6	)	(5.2	)
Purchase of short-term investments	(350.0	)	(75.0	)
Maturity of short-term investments	225.0		300.0
Cash from (used for) derivative financial instruments	1.1		(30.7	)
Loans issued and other investments	—		—
Acquisition of subsidiaries (net of cash acquired)	—		—
Net cash provided by (used in) investing activities	(182.7	)	150.5
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid	—		—
Purchase of shares	(213.5	)	—
Net proceeds from issuance of shares	10.6		13.0
Net proceeds from issuance of notes	—		—
Repayment of debt	(1.2	)	(1.2	)
Tax benefit from share-based payments	—		—
Net cash provided by (used in) financing activities	(204.1	)	11.8
Net cash flows	(392.6	)	(6.1	)
Effect of changes in exchange rates on cash	(2.7	)	9.8
Net increase (decrease) in cash and cash equivalents	(395.3	)	3.7

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations ^1,2 

	Three months ended,
		Apr 3,		Jul 3,		Oct 2,		Dec 31,		Apr 2,
		2016		2016		2016		2016		2017
(in millions EUR, except per share data)
Net system sales 3		859.8		1,265.4		1,257.7		1,289.1		1,215.8
Net service and field option sales 3		473.4		474.2		556.9		618.3		727.8
Total net sales		1,333.2		1,739.6		1,814.6		1,907.4		1,943.6
Total cost of sales		(765.1	)	(998.2	)	(980.2	)	(1,006.8	)	(1,019.0	)
Gross profit		568.1		741.4		834.4		900.6		924.6
Other income		23.4		23.5		23.4		23.5		23.9
Research and development costs		(274.7	)	(270.3	)	(273.4	)	(287.4	)	(315.1	)
Selling, general and administrative costs		(88.8	)	(90.4	)	(88.8	)	(106.8	)	(98.6	)
Income from operations		228.0		404.2		495.6		529.9		534.8
Interest and other, net		(3.6	)	(3.6	)	(33.9	)	74.8		(14.1	)
Income before income taxes		224.4		400.6		461.7		604.7		520.7
Benefit from (provision for) income taxes		(26.4	)	(46.8	)	(65.8	)	(80.5	)	(68.6	)
Net income		198.0		353.8		395.9		524.2		452.1
Basic net income per ordinary share		0.46		0.83		0.93		1.23		1.05
Diluted net income per ordinary share 4		0.46		0.83		0.93		1.22		1.05
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic		427.0		424.5		423.8		427.1		430.1
Diluted 4		429.1		426.5		425.8		429.2		432.3

ASML - Quarterly Summary Ratios and other data ^1,2 

	Apr 3,		Jul 3,		Oct 2,		Dec 31,		Apr 2,
	2016		2016		2016		2016		2017
(in millions EUR, except otherwise indicated)
Gross profit as a percentage of net sales	42.6	%	42.6	%	46.0	%	47.2	%	47.6	%
Income from operations as a percentage of net sales	17.1	%	23.2	%	27.3	%	27.8	%	27.5	%
Net income as a percentage of net sales	14.9	%	20.3	%	21.8	%	27.5	%	23.3	%
Income taxes as a percentage of income before income taxes	11.7	%	11.7	%	14.2	%	13.3	%	13.2	%
Shareholders’ equity as a percentage of total assets	63.2	%	61.3	%	57.5	%	57.1	%	59.1	%
Sales of lithography systems (in units) 5	33		46		40		38		44
Value of systems backlog (EUR millions) 6	3,018		3,371		3,462		3,961		4,509
Lithography systems backlog (in units) 5	76		73		76		83		94
Value of booked systems (EUR millions) 6	835		1,566		1,415		1,580		1,894
Net bookings lithography systems (in units) 5	30		43		43		44		55
Number of payroll employees in FTEs	12,407		12,598		12,933		13,991		14,483
Number of temporary employees in FTEs	2,492		2,569		2,599		2,656		2,657

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets ^1,2 

	Apr 3,	Jul 3,	Oct 2,	Dec 31,	Apr 2,
	2016	2016	2016	2016	2017
(in millions EUR)
ASSETS
Cash and cash equivalents	2,063.4	1,926.1	2,913.0	2,906.9	2,910.6
Short-term investments	1,075.0	1,000.0	1,400.0	1,150.0	925.0
Accounts receivable, net	753.2	732.4	858.4	700.2	864.8
Finance receivables, net	446.5	524.0	663.5	447.4	346.9
Current tax assets	96.0	178.0	143.5	11.6	137.0
Inventories, net	2,750.0	2,715.3	2,696.9	2,780.9	2,995.7
Other assets	502.1	504.7	540.4	560.4	589.6
Total current assets	7,686.2	7,580.5	9,215.7	8,557.4	8,769.6
Finance receivables, net	102.2	105.7	71.8	117.2	213.6
Deferred tax assets	47.4	50.0	39.1	34.9	34.5
Other assets	483.8	641.2	623.2	612.3	621.1
Goodwill	2,537.7	2,603.7	2,571.0	4,873.9	4,784.1
Other intangible assets, net	706.0	713.5	694.0	1,323.0	1,279.5
Property, plant and equipment, net	1,580.3	1,608.9	1,587.4	1,687.2	1,622.4
Total non-current assets	5,457.4	5,723.0	5,586.5	8,648.5	8,555.2
Total assets	13,143.6	13,303.5	14,802.2	17,205.9	17,324.8
LIABILITIES AND SHAREHOLDERS’ EQUITY
Total current liabilities	3,246.8	3,720.1	3,272.2	3,280.6	2,875.4
Long-term debt	1,144.3	901.9	2,390.6	3,071.8	3,040.3
Deferred and other tax liabilities	138.0	196.4	222.1	396.9	410.1
Provisions	—	12.6	16.5	20.5	20.5
Accrued and other liabilities	311.1	323.3	387.6	615.7	735.5
Total non-current liabilities	1,593.4	1,434.2	3,016.8	4,104.9	4,206.4
Total liabilities	4,840.2	5,154.3	6,289.0	7,385.5	7,081.8
Total shareholders’ equity	8,303.4	8,149.2	8,513.2	9,820.4	10,243.0
Total liabilities and shareholders’ equity	13,143.6	13,303.5	14,802.2	17,205.9	17,324.8

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows ^1,2  

	Three months ended,
		Apr 3,		Jul 3,		Oct 2,		Dec 31,		Apr 2,
		2016		2016		2016		2016		2017
(in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income		198.0		353.8		395.9		524.2		452.1
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization		82.0		84.1		87.7		103.1		110.1
Impairment		0.5		0.4		1.4		1.2		0.2
Loss on disposal of property, plant and equipment		1.2		0.9		1.7		1.4		0.3
Share-based payments		13.2		10.9		11.6		12.0		13.5
Allowance for doubtful receivables		0.9		0.8		0.7		0.8		1.2
Allowance for obsolete inventory		36.6		22.5		2.9		11.0		29.3
Deferred income taxes		(4.5	)	(6.6	)	37.2		(26.7	)	16.3
Changes in assets and liabilities		(333.7	)	14.3		(541.8	)	566.3		(791.4	)
Net cash provided by (used in) operating activities		(5.8	)	481.1		(2.7	)	1,193.3		(168.4	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment		(55.2	)	(98.9	)	(66.3	)	(95.9	)	(38.6	)
Purchase of intangible assets		(3.6	)	(1.3	)	(2.6	)	(0.9	)	(5.2	)
Purchase of short-term investments		(350.0	)	(350.0	)	(770.0	)	(1,050.0	)	(75.0	)
Maturity of short-term investments		225.0		425.0		370.0		1,300.0		300.0
Cash from (used for) derivative financial instruments		1.1		7.7		(14.4	)	(9.4	)	(30.7	)
Loans issued and other investments		—		(6.0	)	(1.2	)	(0.2	)	—
Acquisition of subsidiaries		—		—		—		(2,641.3	)	—
Net cash provided by (used in) investing activities		(182.7	)	(23.5	)	(484.5	)	(2,497.7	)	150.5
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		—		(445.9	)	—		—		—
Purchase of shares		(213.5	)	(171.9	)	(14.6	)	—		—
Net proceeds from issuance of shares		10.6		12.1		11.7		548.3		13.0
Net proceeds from issuance of notes		—		—		1,484.7		745.9		—
Repayment of debt		(1.2	)	(1.2	)	(1.1	)	(1.2	)	(1.2	)
Tax benefit from share-based payments		—		0.1		0.5		0.3		—
Net cash provided by (used in) financing activities		(204.1	)	(606.8	)	1,481.2		1,293.3		11.8
Net cash flows		(392.6	)	(149.2	)	994.0		(11.1	)	(6.1	)
Effect of changes in exchange rates on cash		(2.7	)	11.9		(7.1	)	5.0		9.8
Net increase (decrease) in cash and cash equivalents		(395.3	)	(137.3	)	986.9		(6.1	)	3.7

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of Preparation

The accompanying Summary Consolidated Financial Statements are stated in millions of euros unless indicated otherwise. The accompanying Summary Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("US GAAP"). For further details on our Summary of Significant Accounting Policies refer to the Notes to the Consolidated Financial Statements as recorded in our Annual Report on Form 20-F which is available on www.asml.com. Further disclosures, as required under US GAAP in annual reports, are not included in the Summary Consolidated Financial Statements.

ASML – Reconciliation US GAAP – IFRS ^1,2 

Net income	Three months ended,
	Apr 3,		Apr 2,
	2016		2017
(in millions EUR)
Net income based on US GAAP	198.0		452.1
Development expenditures (see Note 1)	44.9		5.8
Income taxes (see Note 2)	(13.7	)	3.1
Other	1.6		(0.1	)
Net income based on IFRS	230.8		460.9

Notes to the reconciliation from US GAAP to IFRS

Note 1 Development expenditures

Under US GAAP, ASML applies ASC 730, "Research and Development". In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Under IFRS, ASML applies IAS 38, "Intangible Assets". In accordance with IAS 38, ASML capitalizes certain development expenditures that are amortized over the expected useful life of the related product generally ranging between one and five years. Amortization starts when the developed product is ready for volume production.

Note 2 Income taxes

Under US GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under US GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

Under IFRS, ASML applies IAS 12, "Income Taxes". In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

This document contains statements relating to certain projections and business trends that are forward-looking, including statements with respect to expected trends and outlook, including expected customer insertion of EUV in volume manufacturing, including expected volume orders, systems backlog, expected financial results and trends for the second quarter of 2017, including expected sales, other income, gross margin, R&D and SG&A expenses, and effective annualized tax rate, annual revenue opportunity for ASML and EPS potential by 2020 with significant further growth potential into the next decade, including further growth potential into the next decade, expected industry trends and expected trends in the business environment, including our expectation that the trends exhibited in the first quarter of 2017 will continue in the second quarter of 2017 and our expectation of healthy demand through the end of 2017, statements with respect to EUV targets, manufacturing, supply chain and service capabilities, and ASML’s commitment to secure system performance, shipments and support for volume manufacturing, including availability, productivity, throughput and shipments, including timing of shipments and the ability to support a larger installed base, shrink being a key driver supporting innovation and providing long-term industry growth, lithography enabling affordable shrink and delivering value to customers, expected industry adoption of EUV and statements with respect to the intent of customers to insert EUV into production, the extension of EUV beyond the next decade, the expected continuation of Moore's law and that EUV will continue to enable Moore’s law and drive long term value for ASML beyond the next decade, intention to return excess cash to shareholders, and statements about our proposed dividend, dividend policy and intention to repurchase shares and statements with respect to the share repurchase plan. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "targets", "commits to secure" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about the business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of general economic conditions on consumer confidence and demand for our customers' products, competitive products and pricing, the impact of any manufacturing efficiencies and capacity constraints, performance of our systems, the continuing success of technology advances and the related pace of new product development and customer acceptance of new products including EUV, the number and timing of EUV systems expected to be shipped and recognized in revenue, delays in EUV systems production and development and volume production by customers, including meeting development requirements for volume production, that demand for EUV systems being sufficient to result in utilization of EUV facilities in which ASML has made significant investments, our ability to enforce patents and protect intellectual property rights, the risk of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates, changes in tax rates, available cash and liquidity, our ability to refinance our indebtedness, distributable reserves for dividend payments and share repurchases and timing of resumption of the share repurchase plan, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

¹   These financial statements are unaudited.

²   Numbers have been rounded.

³  As per January 1, 2017, ASML presents net sales with respect to metrology and inspection systems as part of Net system sales instead of Net service and field option sales. The comparative numbers have been adjusted to reflect this change in accounting policy.

⁴   The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans and the issuance of shares under ASML share plans for periods in which exercises or issuances would have a dilutive effect. The calculation of diluted net income per ordinary share does not assume exercise of such options or issuance of shares when such exercises or issuance would be anti-dilutive.

⁵      Lithography systems do not include metrology and inspection systems.

⁶ Our systems backlog and net bookings include all system sales orders for which written authorizations have been accepted (for EUV starting with the NXE:3350B). As per January 1, 2017 our systems backlog and net bookings also include metrology and inspection systems.